About The Well Bioscience
The Well Bioscience is a company based in Newark (United States) founded in 2015. It operates as a B2B. The Well Bioscience offers products and services including VitroGel® Hydrogel, VitroINK Bioinks, and Cyto3D® Live-Dead Assay Kit. The Well Bioscience operates in a competitive market with competitors including Pluri, AIM Biotech, Celloid, S-BIO and ExCel Matrix Biological Devices, among others.
- Headquarter Newark, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Thewell Bioscience Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of The Well Bioscience
The Well Bioscience offers a comprehensive portfolio of products and services, including VitroGel® Hydrogel, VitroINK Bioinks, and Cyto3D® Live-Dead Assay Kit.
Biofunctional hydrogel for 3D cell models and assays
Xeno-free bioink for 3D printing without curing
Kit for measuring cell viability in 3D cultures
People of The Well Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of The Well Bioscience
Detailed funding history for The Well Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by The Well Bioscience
Investment portfolio details for The Well Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - The Well Bioscience
Detailed financials for The Well Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
The Well Bioscience Comparisons
Peer comparison for The Well Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of The Well Bioscience
The Well Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pluri, AIM Biotech, Celloid, S-BIO and ExCel Matrix Biological Devices, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation cell-based products are developed across multiple industries.
|
|
| Locked | Locked | Locked |
Microfluidic 3D cell culture systems are developed and manufactured.
|
|
| Locked | Locked | Locked |
3D cell culture solutions for drug development are provided.
|
|
| Locked | Locked | Locked |
Glycan analysis services and kits are offered by S-BIO.
|
|
| Locked | Locked | Locked |
Proprietary 3D cell culture technologies are provided for tissue engineering.
|
Detailed competitors of The Well Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on The Well Bioscience
Complete news archive for The Well Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about The Well Bioscience
The Well Bioscience was founded in 2015.
The Well Bioscience is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
TheWell Bioscience creates xeno-free hydrogels like VitroGel for advanced 3D cell culture, supporting organoids, stem cells, and bioprinting. They enable applications in precision medicine, cell therapy, and biomanufacturing by mimicking human microenvironments. Based in Monmouth Junction, New Jersey, USA, the company collaborates with academia, hospitals, and pharmaceutical industries to advance biomedicine worldwide, focusing on innovative solutions for drug screening and tissue engineering.
The Well Bioscience's top competitors include Pluri, Celloid and ExCel Matrix Biological Devices.
The Well Bioscience offers VitroGel® Hydrogel, VitroINK Bioinks, and Cyto3D® Live-Dead Assay Kit.